Annual SGA
$49.92 M
+$1.21 M+2.47%
December 31, 2023
Summary
- As of February 26, 2025, AVIR annual SGA is $49.92 million, with the most recent change of +$1.21 million (+2.47%) on December 31, 2023.
- During the last 3 years, AVIR annual SGA has risen by +$28.28 million (+130.68%).
- AVIR annual SGA is now at all-time high.
Performance
AVIR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$11.04 M
-$1.18 M-9.63%
September 30, 2024
Summary
- As of February 26, 2025, AVIR quarterly SGA is $11.04 million, with the most recent change of -$1.18 million (-9.63%) on September 30, 2024.
- Over the past year, AVIR quarterly SGA has dropped by -$1.56 million (-12.38%).
- AVIR quarterly SGA is now -21.90% below its all-time high of $14.14 million, reached on December 31, 2020.
Performance
AVIR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.09 B
-$174.01 M-19.10%
September 30, 2024
Summary
- As of February 26, 2025, AVIR TTM SGA is -$1.09 billion, with the most recent change of -$174.01 million (-19.10%) on September 30, 2024.
- Over the past year, AVIR TTM SGA has dropped by -$1.14 billion (-2238.01%).
- AVIR TTM SGA is now -4096.03% below its all-time high of $27.15 million.
Performance
AVIR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AVIR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | -12.4% | -2238.0% |
| 3 y3 years | +130.7% | -12.4% | -2238.0% |
| 5 y5 years | +1681.5% | -12.4% | -2238.0% |
AVIR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +9.0% | -16.3% | at low | -4096.0% | at low |
| 5 y | 5-year | at high | +1024.8% | -21.9% | +802.2% | -4096.0% | at low |
| alltime | all time | at high | +1681.5% | -21.9% | +802.2% | -4096.0% | at low |
Atea Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $11.04 M(-9.6%) | $47.02 M(-3.2%) |
| Jun 2024 | - | $12.22 M(-0.1%) | $48.58 M(-1.9%) |
| Mar 2024 | - | $12.23 M(+6.1%) | $49.53 M(-0.8%) |
| Dec 2023 | $49.92 M(+2.5%) | $11.53 M(-8.5%) | $49.92 M(-1.6%) |
| Sep 2023 | - | $12.60 M(-4.3%) | $50.75 M(+2.5%) |
| Jun 2023 | - | $13.17 M(+4.4%) | $49.52 M(+1.5%) |
| Mar 2023 | - | $12.62 M(+2.1%) | $48.79 M(+0.1%) |
| Dec 2022 | $48.71 M(+6.4%) | $12.36 M(+8.6%) | $48.71 M(-1.7%) |
| Sep 2022 | - | $11.38 M(-8.5%) | $49.54 M(-1.1%) |
| Jun 2022 | - | $12.44 M(-0.8%) | $50.11 M(+1.1%) |
| Mar 2022 | - | $12.54 M(-4.9%) | $49.57 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $45.78 M(+111.6%) | $13.19 M(+10.5%) | $45.79 M(-2.0%) |
| Sep 2021 | - | $11.94 M(+0.3%) | $46.74 M(+20.4%) |
| Jun 2021 | - | $11.90 M(+35.9%) | $38.83 M(+33.1%) |
| Mar 2021 | - | $8.76 M(-38.1%) | $29.18 M(+34.8%) |
| Dec 2020 | $21.64 M(+387.6%) | $14.14 M(+251.0%) | $21.64 M(+147.0%) |
| Sep 2020 | - | $4.03 M(+79.2%) | $8.76 M(+43.8%) |
| Jun 2020 | - | $2.25 M(+83.7%) | $6.09 M(+58.5%) |
| Mar 2020 | - | $1.22 M(-2.9%) | $3.84 M(+46.8%) |
| Dec 2019 | $4.44 M(+58.4%) | $1.26 M(-7.2%) | $2.62 M(+92.8%) |
| Sep 2019 | - | $1.36 M | $1.36 M |
| Dec 2018 | $2.80 M | - | - |
FAQ
- What is Atea Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual SGA year-on-year change?
- What is Atea Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly SGA year-on-year change?
- What is Atea Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM SGA year-on-year change?
What is Atea Pharmaceuticals annual SGA?
The current annual SGA of AVIR is $49.92 M
What is the all time high annual SGA for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual SGA is $49.92 M
What is Atea Pharmaceuticals annual SGA year-on-year change?
Over the past year, AVIR annual SGA has changed by +$1.21 M (+2.47%)
What is Atea Pharmaceuticals quarterly SGA?
The current quarterly SGA of AVIR is $11.04 M
What is the all time high quarterly SGA for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly SGA is $14.14 M
What is Atea Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AVIR quarterly SGA has changed by -$1.56 M (-12.38%)
What is Atea Pharmaceuticals TTM SGA?
The current TTM SGA of AVIR is -$1.09 B
What is the all time high TTM SGA for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM SGA is $27.15 M
What is Atea Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AVIR TTM SGA has changed by -$1.14 B (-2238.01%)